3.02MMarket Cap
LossP/E TTM
CASI Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-02-25The current valuation score of CASI Pharmaceuticals Inc is 8.80, ranking 7 out of 158 in the Pharmaceuticals industry. Its current P/E ratio is -0.07, which is 0.00% below the recent high of -0.07 and -5570.70% above the recent low of -3.89.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.